Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Salmonella | 13 | 2026 | 45 | 6.280 |
Why?
|
| Neoplasms | 22 | 2024 | 1377 | 5.130 |
Why?
|
| Bacterial Proteins | 7 | 2026 | 741 | 2.500 |
Why?
|
| Salmonella typhimurium | 7 | 2026 | 86 | 2.460 |
Why?
|
| Cell Line, Tumor | 22 | 2026 | 1573 | 2.070 |
Why?
|
| Antineoplastic Agents | 9 | 2017 | 645 | 2.010 |
Why?
|
| Models, Biological | 11 | 2020 | 1193 | 1.760 |
Why?
|
| Bacteria | 7 | 2024 | 337 | 1.650 |
Why?
|
| Probiotics | 3 | 2022 | 57 | 1.550 |
Why?
|
| Genetic Engineering | 6 | 2018 | 114 | 1.390 |
Why?
|
| Colonic Neoplasms | 5 | 2014 | 220 | 1.300 |
Why?
|
| Drug Delivery Systems | 6 | 2021 | 333 | 1.290 |
Why?
|
| Oncolytic Virotherapy | 3 | 2026 | 9 | 1.270 |
Why?
|
| Tumor Microenvironment | 3 | 2024 | 183 | 1.260 |
Why?
|
| Salmonella enterica | 2 | 2019 | 26 | 1.150 |
Why?
|
| Apoptosis | 8 | 2026 | 1100 | 1.120 |
Why?
|
| Biological Therapy | 3 | 2018 | 16 | 1.110 |
Why?
|
| Immunotherapy | 4 | 2024 | 274 | 1.090 |
Why?
|
| Genetic Vectors | 4 | 2026 | 930 | 0.990 |
Why?
|
| H-1 parvovirus | 1 | 2026 | 1 | 0.970 |
Why?
|
| Parvovirus | 1 | 2026 | 25 | 0.960 |
Why?
|
| Green Fluorescent Proteins | 3 | 2023 | 372 | 0.960 |
Why?
|
| Oncolytic Viruses | 1 | 2026 | 10 | 0.960 |
Why?
|
| Adenocarcinoma | 3 | 2014 | 367 | 0.930 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2026 | 605 | 0.860 |
Why?
|
| Microfluidics | 2 | 2016 | 26 | 0.860 |
Why?
|
| Mice | 17 | 2026 | 11185 | 0.860 |
Why?
|
| Microscopy, Fluorescence | 8 | 2015 | 401 | 0.850 |
Why?
|
| Immunologic Memory | 1 | 2026 | 284 | 0.820 |
Why?
|
| Microfluidic Analytical Techniques | 4 | 2013 | 28 | 0.810 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2014 | 29 | 0.810 |
Why?
|
| Hemolysin Proteins | 2 | 2014 | 45 | 0.790 |
Why?
|
| Tumor Cells, Cultured | 4 | 2016 | 426 | 0.790 |
Why?
|
| Spheroids, Cellular | 5 | 2016 | 28 | 0.780 |
Why?
|
| Glucose | 3 | 2016 | 478 | 0.770 |
Why?
|
| Intestinal Mucosa | 2 | 2022 | 254 | 0.750 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2026 | 679 | 0.750 |
Why?
|
| Neoplasms, Experimental | 2 | 2015 | 77 | 0.740 |
Why?
|
| Humans | 40 | 2026 | 65830 | 0.730 |
Why?
|
| Escherichia coli | 3 | 2021 | 718 | 0.710 |
Why?
|
| Animals | 20 | 2026 | 21492 | 0.700 |
Why?
|
| Listeria monocytogenes | 1 | 2021 | 33 | 0.690 |
Why?
|
| Caspase 3 | 1 | 2021 | 108 | 0.670 |
Why?
|
| Lipopolysaccharides | 1 | 2024 | 625 | 0.670 |
Why?
|
| Cell Survival | 5 | 2017 | 588 | 0.670 |
Why?
|
| Cell Culture Techniques | 3 | 2012 | 195 | 0.650 |
Why?
|
| Mucus | 1 | 2020 | 17 | 0.640 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2011 | 44 | 0.630 |
Why?
|
| Cell Nucleus | 2 | 2023 | 634 | 0.630 |
Why?
|
| Interleukin-8 | 1 | 2020 | 96 | 0.620 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 354 | 0.620 |
Why?
|
| Doxorubicin | 4 | 2013 | 98 | 0.620 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 175 | 0.610 |
Why?
|
| Clostridium | 2 | 2010 | 10 | 0.570 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 309 | 0.570 |
Why?
|
| Fluorescent Dyes | 1 | 2019 | 204 | 0.530 |
Why?
|
| Viruses | 1 | 2018 | 82 | 0.520 |
Why?
|
| Necrosis | 3 | 2014 | 147 | 0.520 |
Why?
|
| Bacterial Toxins | 2 | 2015 | 58 | 0.510 |
Why?
|
| Cell Proliferation | 5 | 2021 | 1044 | 0.470 |
Why?
|
| Tissue Culture Techniques | 1 | 2016 | 33 | 0.460 |
Why?
|
| Glutamine | 2 | 2014 | 51 | 0.460 |
Why?
|
| Lactic Acid | 2 | 2014 | 75 | 0.450 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 527 | 0.450 |
Why?
|
| Colony Count, Microbial | 4 | 2019 | 58 | 0.450 |
Why?
|
| Salmonella Infections | 2 | 2014 | 42 | 0.450 |
Why?
|
| Models, Theoretical | 2 | 2014 | 274 | 0.450 |
Why?
|
| Quorum Sensing | 1 | 2015 | 6 | 0.440 |
Why?
|
| Genes, Reporter | 3 | 2013 | 257 | 0.430 |
Why?
|
| Locomotion | 1 | 2015 | 111 | 0.430 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 712 | 0.430 |
Why?
|
| Gold | 4 | 2010 | 235 | 0.430 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2014 | 40 | 0.420 |
Why?
|
| Lipid A | 1 | 2014 | 68 | 0.400 |
Why?
|
| Mice, Inbred C57BL | 3 | 2026 | 3506 | 0.380 |
Why?
|
| Prodrugs | 2 | 2015 | 36 | 0.380 |
Why?
|
| Biological Transport | 4 | 2017 | 292 | 0.380 |
Why?
|
| Hypoxia | 1 | 2014 | 121 | 0.370 |
Why?
|
| Lab-On-A-Chip Devices | 3 | 2019 | 24 | 0.370 |
Why?
|
| Staphylococcus aureus | 1 | 2014 | 183 | 0.370 |
Why?
|
| Cell Communication | 1 | 2013 | 135 | 0.360 |
Why?
|
| Dendritic Cells | 2 | 2026 | 534 | 0.360 |
Why?
|
| Antigens, Neoplasm | 2 | 2023 | 134 | 0.350 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2010 | 5 | 0.320 |
Why?
|
| Gluconeogenesis | 1 | 2010 | 15 | 0.320 |
Why?
|
| Metal Nanoparticles | 2 | 2010 | 191 | 0.320 |
Why?
|
| Cell Hypoxia | 2 | 2007 | 42 | 0.310 |
Why?
|
| Diffusion | 4 | 2015 | 83 | 0.310 |
Why?
|
| Chemotaxis | 2 | 2007 | 51 | 0.300 |
Why?
|
| Genetic Enhancement | 1 | 2008 | 2 | 0.290 |
Why?
|
| Membrane Proteins | 1 | 2014 | 926 | 0.280 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 290 | 0.280 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2008 | 22 | 0.280 |
Why?
|
| Food | 1 | 2008 | 76 | 0.270 |
Why?
|
| Cytokines | 2 | 2022 | 965 | 0.260 |
Why?
|
| Paclitaxel | 1 | 2008 | 102 | 0.260 |
Why?
|
| Chemoreceptor Cells | 1 | 2007 | 5 | 0.260 |
Why?
|
| Ribose | 1 | 2007 | 5 | 0.260 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2024 | 203 | 0.250 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2007 | 38 | 0.250 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 2329 | 0.250 |
Why?
|
| Energy Metabolism | 2 | 2008 | 400 | 0.250 |
Why?
|
| Biosynthetic Pathways | 1 | 2006 | 17 | 0.240 |
Why?
|
| Polyethylene Glycols | 2 | 2021 | 172 | 0.240 |
Why?
|
| Genome, Bacterial | 1 | 2006 | 67 | 0.240 |
Why?
|
| STAT3 Transcription Factor | 1 | 2026 | 70 | 0.230 |
Why?
|
| Half-Life | 2 | 2017 | 81 | 0.230 |
Why?
|
| Computer Simulation | 1 | 2008 | 488 | 0.220 |
Why?
|
| Female | 7 | 2026 | 34420 | 0.220 |
Why?
|
| Interleukin-10 | 1 | 2026 | 165 | 0.220 |
Why?
|
| Time-Lapse Imaging | 2 | 2016 | 21 | 0.220 |
Why?
|
| Mice, Inbred BALB C | 2 | 2019 | 869 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2026 | 216 | 0.220 |
Why?
|
| Estradiol | 1 | 2006 | 260 | 0.220 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2024 | 39 | 0.220 |
Why?
|
| Tissue Distribution | 1 | 2024 | 292 | 0.210 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 1172 | 0.210 |
Why?
|
| Inflammation | 2 | 2022 | 1198 | 0.210 |
Why?
|
| MCF-7 Cells | 2 | 2014 | 65 | 0.200 |
Why?
|
| Phosphorylation | 1 | 2026 | 963 | 0.200 |
Why?
|
| Synthetic Biology | 1 | 2023 | 13 | 0.200 |
Why?
|
| Ovalbumin | 1 | 2023 | 108 | 0.200 |
Why?
|
| Mitochondria | 1 | 2006 | 416 | 0.180 |
Why?
|
| Bacteriolysis | 1 | 2021 | 7 | 0.180 |
Why?
|
| Bacteriological Techniques | 2 | 2015 | 29 | 0.170 |
Why?
|
| Cytoplasm | 1 | 2023 | 283 | 0.170 |
Why?
|
| Adenoviridae | 1 | 2021 | 132 | 0.170 |
Why?
|
| Vaccination | 1 | 2023 | 388 | 0.160 |
Why?
|
| Macrophages | 1 | 2026 | 1042 | 0.160 |
Why?
|
| HT29 Cells | 1 | 2020 | 28 | 0.160 |
Why?
|
| Movement | 1 | 2021 | 166 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2013 | 218 | 0.140 |
Why?
|
| Clinical Studies as Topic | 1 | 2018 | 1 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 449 | 0.140 |
Why?
|
| Cancer Vaccines | 1 | 2018 | 51 | 0.140 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 95 | 0.140 |
Why?
|
| Glutamic Acid | 2 | 2010 | 105 | 0.130 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 375 | 0.130 |
Why?
|
| Culture Media | 2 | 2008 | 78 | 0.130 |
Why?
|
| Breast Neoplasms | 1 | 2006 | 1235 | 0.130 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 296 | 0.130 |
Why?
|
| Treatment Outcome | 2 | 2018 | 5834 | 0.130 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2016 | 13 | 0.120 |
Why?
|
| Amino Acids | 2 | 2008 | 148 | 0.120 |
Why?
|
| Fibroblasts | 2 | 2010 | 423 | 0.120 |
Why?
|
| Bacterial Vaccines | 1 | 2016 | 79 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 859 | 0.110 |
Why?
|
| Microscopy, Video | 1 | 2015 | 38 | 0.110 |
Why?
|
| Methyl-Accepting Chemotaxis Proteins | 1 | 2014 | 2 | 0.110 |
Why?
|
| Selection, Genetic | 1 | 2015 | 90 | 0.110 |
Why?
|
| Transcription Factors | 1 | 2023 | 1561 | 0.110 |
Why?
|
| Carbohydrates | 1 | 2014 | 40 | 0.110 |
Why?
|
| Blood Vessels | 1 | 2014 | 63 | 0.110 |
Why?
|
| Kinetics | 2 | 2014 | 758 | 0.100 |
Why?
|
| Cell Shape | 1 | 2014 | 12 | 0.100 |
Why?
|
| Nanostructures | 2 | 2006 | 187 | 0.100 |
Why?
|
| Child | 1 | 2023 | 4651 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 233 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2014 | 312 | 0.100 |
Why?
|
| Arabinose | 1 | 2013 | 4 | 0.100 |
Why?
|
| Endothelial Cells | 1 | 2014 | 216 | 0.090 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 710 | 0.090 |
Why?
|
| Luminescent Proteins | 1 | 2013 | 129 | 0.090 |
Why?
|
| Cloning, Molecular | 1 | 2013 | 387 | 0.090 |
Why?
|
| Plasmids | 1 | 2013 | 294 | 0.090 |
Why?
|
| Bacterial Adhesion | 2 | 2021 | 65 | 0.090 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 1980 | 0.090 |
Why?
|
| Male | 4 | 2021 | 31403 | 0.080 |
Why?
|
| Algorithms | 2 | 2007 | 1060 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 140 | 0.080 |
Why?
|
| Particle Size | 2 | 2010 | 432 | 0.080 |
Why?
|
| Malate Dehydrogenase | 1 | 2010 | 3 | 0.080 |
Why?
|
| Tricarboxylic Acids | 1 | 2010 | 2 | 0.080 |
Why?
|
| Least-Squares Analysis | 1 | 2010 | 24 | 0.080 |
Why?
|
| Fluorescein | 1 | 2010 | 13 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 1719 | 0.080 |
Why?
|
| Anions | 1 | 2010 | 32 | 0.080 |
Why?
|
| Isotope Labeling | 1 | 2010 | 69 | 0.080 |
Why?
|
| Cations | 1 | 2010 | 64 | 0.080 |
Why?
|
| Oxygen | 1 | 2012 | 323 | 0.080 |
Why?
|
| Biomarkers | 1 | 2015 | 1502 | 0.070 |
Why?
|
| Light | 2 | 2008 | 195 | 0.070 |
Why?
|
| Acridine Orange | 1 | 2008 | 2 | 0.070 |
Why?
|
| Cell Growth Processes | 1 | 2008 | 35 | 0.070 |
Why?
|
| Phantoms, Imaging | 1 | 2010 | 242 | 0.070 |
Why?
|
| Staining and Labeling | 1 | 2008 | 128 | 0.070 |
Why?
|
| Molecular Weight | 1 | 2008 | 194 | 0.070 |
Why?
|
| Receptors, Amino Acid | 1 | 2007 | 2 | 0.060 |
Why?
|
| Equipment Design | 1 | 2008 | 374 | 0.060 |
Why?
|
| Carbon Isotopes | 1 | 2006 | 17 | 0.060 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2007 | 89 | 0.060 |
Why?
|
| Gene Transfer Techniques | 1 | 2008 | 325 | 0.060 |
Why?
|
| Luciferases | 1 | 2006 | 107 | 0.060 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2006 | 85 | 0.060 |
Why?
|
| Cell Cycle | 1 | 2008 | 398 | 0.060 |
Why?
|
| Glutathione | 1 | 2006 | 55 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2006 | 225 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 297 | 0.060 |
Why?
|
| Oxygen Consumption | 1 | 2006 | 213 | 0.060 |
Why?
|
| DNA | 2 | 2008 | 853 | 0.060 |
Why?
|
| Cell Death | 1 | 2006 | 289 | 0.050 |
Why?
|
| Mice, Inbred C3H | 1 | 2003 | 173 | 0.050 |
Why?
|
| Cell Line | 1 | 2007 | 2031 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2003 | 518 | 0.050 |
Why?
|
| Chemokine CCL2 | 1 | 2021 | 61 | 0.040 |
Why?
|
| Liposomes | 1 | 2021 | 118 | 0.040 |
Why?
|
| Swimming | 1 | 2021 | 30 | 0.040 |
Why?
|
| Monocytes | 1 | 2021 | 362 | 0.040 |
Why?
|
| Hydrogels | 1 | 2021 | 127 | 0.040 |
Why?
|
| Mutation | 1 | 2007 | 2675 | 0.030 |
Why?
|
| Scattering, Radiation | 1 | 2008 | 72 | 0.020 |
Why?
|
| COS Cells | 1 | 2008 | 180 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2008 | 465 | 0.020 |
Why?
|
| Photochemistry | 1 | 2006 | 22 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2006 | 120 | 0.010 |
Why?
|
| Nanotechnology | 1 | 2006 | 139 | 0.010 |
Why?
|
| Drug Carriers | 1 | 2006 | 190 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 1332 | 0.010 |
Why?
|